Pfizer reports Q3 loss amid declining COVID-19 products sales
Nov 01, 2023
New York [US], November 1: U.S. drugmaker Pfizer reported Tuesday a loss of 2.4 billion U.S. dollars for the third quarter due to the continued declining sales of its COVID-19 vaccine and treatments.
Read More ..